YUSUKE AOKI

709 total citations
47 papers, 575 citations indexed

About

YUSUKE AOKI is a scholar working on Biotechnology, Oncology and Molecular Biology. According to data from OpenAlex, YUSUKE AOKI has authored 47 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Biotechnology, 16 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in YUSUKE AOKI's work include Cancer Research and Treatments (29 papers), Virus-based gene therapy research (13 papers) and Cancer-related Molecular Pathways (9 papers). YUSUKE AOKI is often cited by papers focused on Cancer Research and Treatments (29 papers), Virus-based gene therapy research (13 papers) and Cancer-related Molecular Pathways (9 papers). YUSUKE AOKI collaborates with scholars based in Japan, United States and France. YUSUKE AOKI's co-authors include Robert M. Hoffman, Qinghong Han, NORIYUKI MASAKI, Kazuyuki Hamada, Michael Bouvet, Yutaro Kubota, Koya Obara, Jun Yamamoto, Takuya Tsunoda and Yasunori Tome and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

YUSUKE AOKI

44 papers receiving 573 citations

Peers

Countries citing papers authored by YUSUKE AOKI

Since Specialization

Citations

This map shows the geographic impact of YUSUKE AOKI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by YUSUKE AOKI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites YUSUKE AOKI more than expected).

Fields of papers citing papers by YUSUKE AOKI

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by YUSUKE AOKI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by YUSUKE AOKI. The network helps show where YUSUKE AOKI may publish in the future.

Co-authorship network of co-authors of YUSUKE AOKI

This figure shows the co-authorship network connecting the top 25 collaborators of YUSUKE AOKI. A scholar is included among the top collaborators of YUSUKE AOKI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with YUSUKE AOKI. YUSUKE AOKI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered Methioninase-expressing Tumor-targetingSalmonella typhimuriumA1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine 2025 ·Cancer Genomics & Proteomics ·Yutaro Kubota, Ming Zhao, Qinghong Han, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Sei Morinaga, (unknown), (unknown), Michael Bouvet, Koichi Kubota, Takuya Tsunoda, Robert M. Hoffman	1
2	Targeting Methionine Addiction of Osteosarcoma with Methionine Restriction to Overcome Drug Resistance: A New Paradigm for a Recalcitrant Disease 2025 ·Cancers ·YUSUKE AOKI, Yutaro Kubota, NORIYUKI MASAKI, Yasunori Tome, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	1
3	Precise Non-invasive Imaging Mouse Model of Pancreatic Cancer: Very Narrow Band-width Laser Fluorescence Excitation of Green Fluorescent Protein Provides Ultra-bright Tumor Images With no Skin Autofluorescence 2024 ·Cancer Diagnosis & Prognosis ·Yutaro Kubota, (unknown), (unknown), (unknown), (unknown), YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Sei Morinaga, Takuya Tsunoda, Robert M. Hoffman	1
4	Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression 2024 ·Anticancer Research ·YUSUKE AOKI, Yutaro Kubota, NORIYUKI MASAKI, Koya Obara, Yasunori Tome, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	1
5	Long-lasting Limb Salvage After Malignant Femoral-Bone Tumor Resection Reconstructed With a Thin-mantle Titanium Stem Fixated With Cement 2023 ·Anticancer Research ·YUSUKE AOKI, Yasunori Tome, Hiromichi Oshiro, (unknown), (unknown), Robert M. Hoffman, Kotaro Nishida	1
6	The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression ofC-MYC 2023 ·Cancer Genomics & Proteomics ·YUSUKE AOKI, Yutaro Kubota, Qinghong Han, NORIYUKI MASAKI, Koya Obara, Michael Bouvet, Sant P. Chawla, Yasunori Tome, Kotaro Nishida, Robert M. Hoffman	5
7	Denosumab administration for bone metastases from solid tumors: a retrospective cross-sectional study 2023 ·BMC Cancer ·(unknown), Hiromichi Oshiro, (unknown), (unknown), YUSUKE AOKI, Yasunori Tome, Kotaro Nishida	5
8	Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically-incurable disease 2023 ·Biochemical and Biophysical Research Communications ·Yutaro Kubota, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Kazuyuki Hamada, Qinghong Han, Michael Bouvet, Takuya Tsunoda, Robert M. Hoffman	13
9	Asymmetric and symmetric protein arginine methylation in methionine-addicted human cancer cells 2023 ·PLoS ONE ·(unknown), (unknown), YUSUKE AOKI, Yutaro Kubota, Robert M. Hoffman, Steven Clarke	3
10	Old-age-induced obesity reversed by a methionine-deficient diet or oral administration of recombinant methioninase-producing Escherichia coli in C57BL/6 mice 2023 ·Aging ·Yutaro Kubota, Qinghong Han, Jose Reynoso, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Kazuyuki Hamada, Michael Bouvet, Takuya Tsunoda, Robert M. Hoffman	6
11	Oncogenes and Methionine Addiction of Cancer: Role ofc-MYC 2023 ·Cancer Genomics & Proteomics ·YUSUKE AOKI, Qinghong Han, Yutaro Kubota, NORIYUKI MASAKI, Koya Obara, Yasunori Tome, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	17
12	The First Mouse Model of Meckel’s Diverticulum Carcinoma 2022 ·In Vivo ·NORIYUKI MASAKI, Yutaka Yonemura, (unknown), (unknown), (unknown), Yutaro Kubota, YUSUKE AOKI, Michael Bouvet, Jun Miyazaki, Robert M. Hoffman	0
13	Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model 2022 ·Anticancer Research ·NORIYUKI MASAKI, Qinghong Han, (unknown), (unknown), (unknown), Justin C. Wu, Koya Obara, Yutaro Kubota, YUSUKE AOKI, Michael Bouvet, Robert M. Hoffman	12
14	Deletion ofMTAPHighly Sensitizes Osteosarcoma Cells to Methionine Restriction With Recombinant Methioninase 2022 ·Cancer Genomics & Proteomics ·YUSUKE AOKI, Yasunori Tome, Qinghong Han, Jun Yamamoto, Kazuyuki Hamada, NORIYUKI MASAKI, Yutaro Kubota, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	17
15	Long-term Stable Disease in a Rectal-cancer Patient Treated by Methionine Restriction With Oral Recombinant Methioninase and a Low-methionine Diet 2022 ·Anticancer Research ·Yutaro Kubota, Qinghong Han, Kazuyuki Hamada, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Takuya Tsunoda, Robert M. Hoffman	42
16	Obesity Strongly Promotes Growth of Mouse MC38 Colon Cancer in an Orthotopic-syngeneic C57BL/6 Mouse Model 2022 ·In Vivo ·Kazuyuki Hamada, Yutaro Kubota, YUSUKE AOKI, Norihiko Sugisawa, Jun Yamamoto, Yoshihiko Tashiro, Michael Bouvet, Takuya Tsunoda, Robert M. Hoffman	2
17	Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model 2021 ·Anticancer Research ·YUSUKE AOKI, Yasunori Tome, (unknown), Jun Yamamoto, Kazuyuki Hamada, Qinghong Han, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	23
18	Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models 2021 ·Cancer Genomics & Proteomics ·YUSUKE AOKI, Jun Yamamoto, Yasunori Tome, Kazuyuki Hamada, NORIYUKI MASAKI, Sachiko Inubushi, Yoshihiko Tashiro, Michael Bouvet, Itaru Endo, Kotaro Nishida, Robert M. Hoffman	22
19	Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation 2021 ·Biochemistry and Biophysics Reports ·YUSUKE AOKI, Yasunori Tome, Qinghong Han, Jun Yamamoto, Kazuyuki Hamada, NORIYUKI MASAKI, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	22
20	Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells 2021 ·Anticancer Research ·Jun Yamamoto, YUSUKE AOKI, Qinghong Han, Norihiko Sugisawa, (unknown), Kazuyuki Hamada, Hiroto Nishino, Sachiko Inubushi, Kentaro Miyake, Ryusei Matsuyama, Michael Bouvet, Itaru Endo, Robert M. Hoffman	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact